Brief: Vitrolife Prelim Q2 EBITDA Up At SEK 134 Mln
July 9 (Reuters) - Vitrolife AB VITR.ST :
* SAID ON THURSDAY Q2 SALES AMOUNTED TO SEK 382 (209) MLN
* PRELIMINARY Q2 EBITDA AMOUNTED TO SEK 134 (40) MLN
* FLUCTUATIONS IN EXCHANGE RATES NEGATIVELY IMPACTED EBITDA
BY SEK
15 MLN
Source text for Eikon: urn:newsml:reuters.com:*:nWkr4nBT9P
Further company coverage: VITR.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))